The goal of the conference is straightforward and timely: “Identify and discuss the emerging strategies for implementing a transparent prescription drug pricing benchmark and motivate attendees to begin to solve the problem together as an industry.”
The conference will be held in Washington DC, on May 26-27, 2010, and moderated by Ben Sasse, Ph.D., U.S. assistant Secretary of Health and Human Services, 2007-2009, currently Public Policy Faculty Member, LBJ School of Public Affairs, University of Texas.
The speakers will address the historical significance of pricing models and their substantial impact in the industry, the pros and cons of staying with the current model, as well as offer compelling arguments to develop the method to determine the eventual pricing benchmark to replace AWP, and what that new benchmark will mean to business. Attendees will be challenged to define the standards which will drive the industry to develop a new prescription drug pricing benchmark.
The following speakers have been added since the original announcement on March 3, 2010.
- Thomas Barker, Former Acting General Counsel and Policy Advisor, Department of Health and Human Services (HHS); Foley Hoag, Washington, D.C.
- Yaron Brook, Ph.D., President, Ayn Rand Institute; Executive Director, Ayn Rand Center of Individual Rights
- Ted Crooks, General Manager, Global Analytics Inc.
- Kelli D. Littlejohn, R.Ph., Pharm.D., Director of Pharmacy, Alabama Medicaid Agency
- Carol Herrmann-Steckel, MPH, Commissioner, Alabama Medicaid Agency
- The Honorable Tom Davis, U.S. Congressman, 1995-2008, former chair, House Committee on Government Reform and Oversight
- David Cutler, PhD, Senior Health Care Advisor, Obama Presidential Campaign, member of Council of Economic Advisors and National Economic Council for President Clinton, Professor of Applied Economics, Harvard University
- Charlie Baker, Secretary of Administration and Finance 1994-1998, CEO of Harvard Pilgrim Health Care, currently in a bid to run for Governor of Massachusetts.